相似文献
1
Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases.
Emerg Infect Dis. 1999 Jan-Feb;5(1):54-64. doi: 10.3201/eid0501.990107.
2
Passive immunization of the human vagina.
Hum Vaccin Immunother. 2022 Apr 29;18(2):1965423. doi: 10.1080/21645515.2021.1965423. Epub 2021 Sep 2.
3
Comparison of IgA versus IgG monoclonal antibodies for passive immunization of the murine respiratory tract.
Virus Res. 1992 Apr;23(1-2):1-12. doi: 10.1016/0168-1702(92)90063-f.
4
Transgenic commensals as mucosal protectants.
Nat Biotechnol. 2000 Oct;18(10):1038-9. doi: 10.1038/80220.
5
Transmission of IgA and IgG monoclonal antibodies to mucosal fluids following intranasal or parenteral delivery.
Int Arch Allergy Immunol. 2000 Jun;122(2):143-50. doi: 10.1159/000024370.
6
Induction of a mucosal immune response by oral immunization. An overview.
Z Erkr Atmungsorgane. 1991;177(1-2):20-34.
7
Preventing sexual transmission of HSV and HIV: the challenge for active and passive immunization of mucosal surfaces.
Biotechnol Genet Eng Rev. 2002;19:121-38. doi: 10.1080/02648725.2002.10648026.
8
Preventing infectious disease with passive immunization.
Microbes Infect. 2000 May;2(6):701-8. doi: 10.1016/s1286-4579(00)00355-5.
9
Recombinant immunoglobulin A: powerful tools for fundamental and applied research.
Trends Biotechnol. 2002 Feb;20(2):65-71. doi: 10.1016/s0167-7799(01)01874-1.
10
Antibody-dependent passive protection of mucosal surfaces.
Hum Vaccin Immunother. 2022 Apr 29;18(2):1899549. doi: 10.1080/21645515.2021.1899549. Epub 2021 May 3.
引用本文的文献
1
Long-term Prophylaxis Against Aerosolized Marburg Virus in Nonhuman Primates With an Afucosylated Monoclonal Antibody.
J Infect Dis. 2023 Nov 13;228(Suppl 7):S701-S711. doi: 10.1093/infdis/jiad278.
2
Clinical Aspects of B Cell Immunodeficiencies: The Past, the Present and the Future.
Cells. 2022 Oct 24;11(21):3353. doi: 10.3390/cells11213353.
3
A single-administration therapeutic interfering particle reduces SARS-CoV-2 viral shedding and pathogenesis in hamsters.
Proc Natl Acad Sci U S A. 2022 Sep 27;119(39):e2204624119. doi: 10.1073/pnas.2204624119. Epub 2022 Sep 8.
4
Cross-Strain Neutralizing and Protective Monoclonal Antibodies against EEEV or WEEV.
Viruses. 2021 Nov 5;13(11):2231. doi: 10.3390/v13112231.
5
Hexavalent sperm-binding IgG antibody released from vaginal film for development of potent on-demand nonhormonal female contraception.
Proc Natl Acad Sci U S A. 2021 Nov 30;118(48). doi: 10.1073/pnas.2107832118.
6
Engineering sperm-binding IgG antibodies for the development of an effective nonhormonal female contraception.
Sci Transl Med. 2021 Aug 11;13(606). doi: 10.1126/scitranslmed.abd5219.
7
Emerging antibody-based products for infectious diseases: Planning for metric ton manufacturing.
Hum Vaccin Immunother. 2022 Apr 29;18(2):1930847. doi: 10.1080/21645515.2021.1930847. Epub 2021 Jul 14.
8
Engineering tetravalent IgGs with enhanced agglutination potencies for trapping vigorously motile sperm in mucin matrix.
Acta Biomater. 2020 Nov;117:226-234. doi: 10.1016/j.actbio.2020.09.020. Epub 2020 Sep 13.
9
Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.
Cell Mol Life Sci. 2021 Feb;78(4):1501-1522. doi: 10.1007/s00018-020-03580-1. Epub 2020 Jul 4.
10
A review on edible vaccines and their prospects.
Braz J Med Biol Res. 2020 Jan 24;53(2):e8749. doi: 10.1590/1414-431X20198749. eCollection 2020.
本文引用的文献
1
Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library.
Nat Biotechnol. 1996 Mar;14(3):309-14. doi: 10.1038/nbt0396-309.
2
Human antibodies by design.
Nat Biotechnol. 1998 Jun;16(6):535-9. doi: 10.1038/nbt0698-535.
3
Topical antibody delivery systems produce sustained levels in mucosal tissue and blood.
Nat Biotechnol. 1998 Feb;16(2):163-7. doi: 10.1038/nbt0298-163.
4
Interaction of antigens and antibodies at mucosal surfaces.
Annu Rev Microbiol. 1997;51:311-40. doi: 10.1146/annurev.micro.51.1.311.
5
Human immunodeficiency virus type 1 mutants that escape neutralization by human monoclonal antibody IgG1b12. off.
J Virol. 1997 Sep;71(9):6869-74. doi: 10.1128/JVI.71.9.6869-6874.1997.
6
Production of secretory immunoglobulin A by a single mammalian cell.
Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6364-8. doi: 10.1073/pnas.94.12.6364.
7
Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice.
Nat Genet. 1997 Feb;15(2):146-56. doi: 10.1038/ng0297-146.
8
Topically applied human recombinant monoclonal IgG1 antibody and its Fab and F(ab')2 fragments protect mice from vaginal transmission of HSV-2.
Virology. 1996 Nov 1;225(1):213-5. doi: 10.1006/viro.1996.0589.
9
Quantitative evaluation of the gastrointestinal absorption of protein into the blood and lymph circulation.
Biol Pharm Bull. 1996 Oct;19(10):1332-7. doi: 10.1248/bpb.19.1332.
10
Residence half-life of IgG administered topically to the mouse vagina.
Biol Reprod. 1996 Jan;54(1):264-9. doi: 10.1095/biolreprod54.1.264.
Zotero 插件